On 3 February 2018
Thyrocare Technologies will hold a meeting of the Board of Directors of the Company on 3 February 2018, to approve the Unaudited Stand-alone as well as Consolidated Financial Results of the Company for the quarter / nine months ended December 31, 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
